Serum ceruloplasmin albumin ratio as a biochemical marker to assist the diagnosis, treatment and prognosis of pulmonary tuberculosis patients

Ramesh, Rakesh Mudaraddi, Ravindra Maradi

Research output: Contribution to journalArticle

Abstract

Pulmonary tuberculosis (PTB) is a global disease affecting about one third of the world's population with its attendant mortality and morbidity. Acute phase proteins have been used in monitoring the progress of infection. In the present study serum ceruloplasmin and albumin levels were determined in 75 patients of tuberculosis, of which 25 were freshly diagnosed tuberculosis patients (group I), 25 were those who were taking treatment from 1-2 months from the day of diagnosis (group II), 25 were completely treated patients (group III). 25 age and sex matched healthy controls were selected for the study. Mean + SD of serum ceruloplasmin levels in controls, group I, group II, group III was found to be (31.896±7.122) , (61.32± 5.744), (50.400±5.058), (33.920±6.700) respectively. Mean ± albumin levels in controls, group I, group II, group III was found to be (4.502±0.451) , (3.098± 0.881), (3.384±0.593), (4.488±0.646) respectively. Serum ceruloplasmin albumin ratio in group I increases (0.025±0.017) p(0.001) than group II (0.015±0.003) and group III (0.008±0.002) and it was significantly lower in group II and group III. Therefore serum ceruloplasmin albumin ratio can be used as marker to assist the diagnosis, treatment and prognosis of pulmonary tuberculosis patients.

Original languageEnglish
Pages (from-to)494-499
Number of pages6
JournalResearch Journal of Pharmaceutical, Biological and Chemical Sciences
Volume3
Issue number2
Publication statusPublished - 01-04-2012

Fingerprint

Ceruloplasmin
Pulmonary Tuberculosis
Serum Albumin
Albumins
Biomarkers
Tuberculosis
Control Groups
Acute-Phase Proteins
Therapeutics
Morbidity
Mortality
Monitoring
Infection
Serum
Population

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{bca74ba692634849ac3a5393923d3bf3,
title = "Serum ceruloplasmin albumin ratio as a biochemical marker to assist the diagnosis, treatment and prognosis of pulmonary tuberculosis patients",
abstract = "Pulmonary tuberculosis (PTB) is a global disease affecting about one third of the world's population with its attendant mortality and morbidity. Acute phase proteins have been used in monitoring the progress of infection. In the present study serum ceruloplasmin and albumin levels were determined in 75 patients of tuberculosis, of which 25 were freshly diagnosed tuberculosis patients (group I), 25 were those who were taking treatment from 1-2 months from the day of diagnosis (group II), 25 were completely treated patients (group III). 25 age and sex matched healthy controls were selected for the study. Mean + SD of serum ceruloplasmin levels in controls, group I, group II, group III was found to be (31.896±7.122) , (61.32± 5.744), (50.400±5.058), (33.920±6.700) respectively. Mean ± albumin levels in controls, group I, group II, group III was found to be (4.502±0.451) , (3.098± 0.881), (3.384±0.593), (4.488±0.646) respectively. Serum ceruloplasmin albumin ratio in group I increases (0.025±0.017) p(0.001) than group II (0.015±0.003) and group III (0.008±0.002) and it was significantly lower in group II and group III. Therefore serum ceruloplasmin albumin ratio can be used as marker to assist the diagnosis, treatment and prognosis of pulmonary tuberculosis patients.",
author = "Ramesh and Rakesh Mudaraddi and Ravindra Maradi",
year = "2012",
month = "4",
day = "1",
language = "English",
volume = "3",
pages = "494--499",
journal = "Research Journal of Pharmaceutical, Biological and Chemical Sciences",
issn = "0975-8585",
publisher = "RJPBCS",
number = "2",

}

Serum ceruloplasmin albumin ratio as a biochemical marker to assist the diagnosis, treatment and prognosis of pulmonary tuberculosis patients. / Ramesh; Mudaraddi, Rakesh; Maradi, Ravindra.

In: Research Journal of Pharmaceutical, Biological and Chemical Sciences, Vol. 3, No. 2, 01.04.2012, p. 494-499.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum ceruloplasmin albumin ratio as a biochemical marker to assist the diagnosis, treatment and prognosis of pulmonary tuberculosis patients

AU - Ramesh,

AU - Mudaraddi, Rakesh

AU - Maradi, Ravindra

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Pulmonary tuberculosis (PTB) is a global disease affecting about one third of the world's population with its attendant mortality and morbidity. Acute phase proteins have been used in monitoring the progress of infection. In the present study serum ceruloplasmin and albumin levels were determined in 75 patients of tuberculosis, of which 25 were freshly diagnosed tuberculosis patients (group I), 25 were those who were taking treatment from 1-2 months from the day of diagnosis (group II), 25 were completely treated patients (group III). 25 age and sex matched healthy controls were selected for the study. Mean + SD of serum ceruloplasmin levels in controls, group I, group II, group III was found to be (31.896±7.122) , (61.32± 5.744), (50.400±5.058), (33.920±6.700) respectively. Mean ± albumin levels in controls, group I, group II, group III was found to be (4.502±0.451) , (3.098± 0.881), (3.384±0.593), (4.488±0.646) respectively. Serum ceruloplasmin albumin ratio in group I increases (0.025±0.017) p(0.001) than group II (0.015±0.003) and group III (0.008±0.002) and it was significantly lower in group II and group III. Therefore serum ceruloplasmin albumin ratio can be used as marker to assist the diagnosis, treatment and prognosis of pulmonary tuberculosis patients.

AB - Pulmonary tuberculosis (PTB) is a global disease affecting about one third of the world's population with its attendant mortality and morbidity. Acute phase proteins have been used in monitoring the progress of infection. In the present study serum ceruloplasmin and albumin levels were determined in 75 patients of tuberculosis, of which 25 were freshly diagnosed tuberculosis patients (group I), 25 were those who were taking treatment from 1-2 months from the day of diagnosis (group II), 25 were completely treated patients (group III). 25 age and sex matched healthy controls were selected for the study. Mean + SD of serum ceruloplasmin levels in controls, group I, group II, group III was found to be (31.896±7.122) , (61.32± 5.744), (50.400±5.058), (33.920±6.700) respectively. Mean ± albumin levels in controls, group I, group II, group III was found to be (4.502±0.451) , (3.098± 0.881), (3.384±0.593), (4.488±0.646) respectively. Serum ceruloplasmin albumin ratio in group I increases (0.025±0.017) p(0.001) than group II (0.015±0.003) and group III (0.008±0.002) and it was significantly lower in group II and group III. Therefore serum ceruloplasmin albumin ratio can be used as marker to assist the diagnosis, treatment and prognosis of pulmonary tuberculosis patients.

UR - http://www.scopus.com/inward/record.url?scp=84868278984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868278984&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 494

EP - 499

JO - Research Journal of Pharmaceutical, Biological and Chemical Sciences

JF - Research Journal of Pharmaceutical, Biological and Chemical Sciences

SN - 0975-8585

IS - 2

ER -